164 related articles for article (PubMed ID: 24460647)
1. Atypical HUS associated with severe, unexpected antibody-mediated rejection post kidney transplant.
Stevenson S; Mallett A; Oliver K; Hyland V; Hawley C; Malmanche T; Isbel N
Nephrology (Carlton); 2014 Apr; 19 Suppl 1():22-6. PubMed ID: 24460647
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Eculizumab Therapy for Atypical Hemolytic Uremic Syndrome Recurrence and Antibody-Mediated Rejection Progress After Renal Transplantation With Preformed Donor-Specific Antibodies: Case Report.
Yamamoto T; Watarai Y; Futamura K; Okada M; Tsujita M; Hiramitsu T; Goto N; Narumi S; Takeda A; Kobayashi T
Transplant Proc; 2017; 49(1):159-162. PubMed ID: 28104125
[TBL] [Abstract][Full Text] [Related]
3. Atypical hemolytic uremic syndrome recurrence after kidney transplantation.
Matar D; Naqvi F; Racusen LC; Carter-Monroe N; Montgomery RA; Alachkar N
Transplantation; 2014 Dec; 98(11):1205-12. PubMed ID: 24933457
[TBL] [Abstract][Full Text] [Related]
4. Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.
Okumi M; Tanabe K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():9-13. PubMed ID: 26988663
[TBL] [Abstract][Full Text] [Related]
5. Post-transplant recurrence of atypical hemolytic uremic syndrome in a patient with thrombomodulin mutation.
Sinibaldi S; Guzzo I; Piras R; Bresin E; Emma F; Dello Strologo L
Pediatr Transplant; 2013 Dec; 17(8):E177-81. PubMed ID: 24118826
[TBL] [Abstract][Full Text] [Related]
6. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.
Fidler SJ; Irish AB; Lim W; Ferrari P; Witt CS; Christiansen FT
Transpl Immunol; 2013 Jun; 28(4):148-53. PubMed ID: 23665534
[TBL] [Abstract][Full Text] [Related]
7. Midterm Outcomes of 12 Renal Transplant Recipients Treated With Eculizumab to Prevent Atypical Hemolytic Syndrome Recurrence.
Levi C; Frémeaux-Bacchi V; Zuber J; Rabant M; Devriese M; Snanoudj R; Scemla A; Amrouche L; Mejean A; Legendre C; Sberro-Soussan R
Transplantation; 2017 Dec; 101(12):2924-2930. PubMed ID: 28858176
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
Polito MG; Kirsztajn GM
J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
[TBL] [Abstract][Full Text] [Related]
9. [Genetics of aHUS and transplant recurrence].
Bresin E
G Ital Nefrol; 2015; 32 Suppl 64():. PubMed ID: 26479051
[TBL] [Abstract][Full Text] [Related]
10. [Pathophysiology of atypical hemolytic uremic syndrome. Ten years of progress, from laboratory to patient].
Frémeaux-Bacchi V
Biol Aujourdhui; 2013; 207(4):231-40. PubMed ID: 24594571
[TBL] [Abstract][Full Text] [Related]
11. Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.
Mallett A; Hughes P; Szer J; Tuckfield A; Van Eps C; Cambell SB; Hawley C; Burke J; Kausman J; Hewitt I; Parnham A; Ford S; Isbel N
Intern Med J; 2015 Oct; 45(10):1054-65. PubMed ID: 26247170
[TBL] [Abstract][Full Text] [Related]
12. Report of the inefficacy of eculizumab in two cases of severe antibody-mediated rejection of renal grafts.
Burbach M; Suberbielle C; Brochériou I; Ridel C; Mesnard L; Dahan K; Rondeau E; Hertig A
Transplantation; 2014 Nov; 98(10):1056-9. PubMed ID: 24839895
[TBL] [Abstract][Full Text] [Related]
13. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
14. Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody.
Rigothier C; Delmas Y; Roumenina LT; Contin-Bordes C; Lepreux S; Bridoux F; Goujon JM; Bachelet T; Touchard G; Frémeaux-Bacchi V; Combe C
Am J Kidney Dis; 2015 Aug; 66(2):331-6. PubMed ID: 26015278
[TBL] [Abstract][Full Text] [Related]
15. Recurrent atypical haemolytic uraemic syndrome post kidney transplant due to a CD46 mutation in the setting of SMARCAL1-mediated inherited kidney disease.
Chan S; Mallett AJ; Patel C; Francis RS; Johnson DW; Mudge DW; Isbel NM
Nephrology (Carlton); 2017 Feb; 22 Suppl 1():11-14. PubMed ID: 28176476
[TBL] [Abstract][Full Text] [Related]
16. Hemolytic Uremic Syndrome and Kidney Transplantation: A Case Series and Review of the Literature.
Milan Manani S; Virzì GM; Giuliani A; Clementi A; Brocca A; Dissegna D; Martino F; d''Amore ESG; Ronco C
Nephron; 2017; 136(3):245-253. PubMed ID: 28419995
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic Eculizumab Use in Kidney Transplantation: A Review of the Literature and Report of a Case with Atypical Hemolytic Uremic Syndrome.
Kasapoğlu U; Ruhi Ç; Tuğcu M; Boynueğri B; Titiz İ; Hançer VS; Apaydın S
Ann Transplant; 2015 Dec; 20():714-9. PubMed ID: 26621268
[TBL] [Abstract][Full Text] [Related]
18. A 'silent', new polymorphism of factor H and apparent de novo atypical haemolytic uraemic syndrome after kidney transplantation.
Broeders EN; Stordeur P; Rorive S; Dahan K
BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25538218
[TBL] [Abstract][Full Text] [Related]
19. Successful living-related renal transplantation in a patient with factor H antibody-associated atypical hemolytic uremic syndrome.
Hofer J; Giner T; Cortina G; Jungraithmayr T; Masalskiene J; Dobiliene D; Mitkiene R; Pundziene B; Rudaitis S
Pediatr Transplant; 2015 Aug; 19(5):E121-5. PubMed ID: 26037622
[TBL] [Abstract][Full Text] [Related]
20. A single-center experience of post-transplant atypical hemolytic uremic syndrome.
Abu Jawdeh BG; Khan MA
Clin Nephrol; 2023 Aug; 100(2):75-81. PubMed ID: 37288831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
